MedPath

IMT Outcomes in Sufferers of Severe Walking Disabilities and Intensive Care Unit Acquired Weakness

Not Applicable
Recruiting
Conditions
Intensive Care Unit Acquired Weakness
Registration Number
NCT06210763
Lead Sponsor
Cairo University
Brief Summary

Intensive care unit-acquired weakness (ICU-acquired weakness) may be caused by a variety of different causes. Several studies have shown that ICU-acquired weakness occurs in up to 30% of critically ill patients. It affects daily activities, walking, and functional performance

Detailed Description

Forty ICU-acquired weakness elderly patients will be randomly assigned to group A and group B, 20 elderly for each. Both groups will receive chest physiotherapy (cough training, vibration, percussion, rib springing, and postural drainage), 30 minutes of resisted training on upper- and lower-limb muscles (15 min on upper limb and 15 min on lower limb), and 30 minutes of neuromuscular electrical stimulation of lower- and upper-limb muscles (triceps and wrist extensors, dorsiflexors, and quadriceps). sessions will be executed 5 times weekly). Group A only will receive 3-set IMT (two sessions daily via threshold IMT, the set contain 10 repetitions) 5 times weekly. The study duration will be 1 month.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • sufferers with intensive care unit acquired weakness
  • Older sufferers patients with severe walking disability detected by Modified Functional Ambulation Category test,
Exclusion Criteria
  • lower limb amputations
  • orthopedic or spinal disc disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Modified Functional Ambulation Category Testit will be measured after 1 month

it is a category test used to assess walking disability

Secondary Outcome Measures
NameTimeMethod
Partial Pressure of carbon dioxideIt will be measured after 1 month

it is an arterial blood gas test

six-minute walk test,It will be measured after 1 month

distance walked in 6 minute

physical division of short form 36It will be measured after 1 month

it assess physical component of short form 36 quality of life questionnare

Oxygen saturationIt will be measured after 1 month

it is an arterial blood gas test

expiratory muscle strengthIt will be measured after 1 month

it will be measure in cm H2O

time up and go testIt will be measured after 1 month

it is time used to walk a three-meter distance

functional vital capacityIt will be measured after 1 month

the percentage of predicted value of functional vital capacity will be assessed

10-meter walking testIt will be measured after 1 month

it is time used to walk a 10-meter distance

mental division of short form 36It will be measured after 1 month

it assess mental component of short form 36 quality of life questionnare

forced expiatory volume in the first second of expirationIt will be measured after 1 month

the percentage of predicted value of FEV1 will be assessed

Partial Pressure of OxygenIt will be measured after 1 month

it is an arterial blood gas test

30-second sit to standIt will be measured after 1 month

number of (sit to stand) done in 30 seconds

inspiratory muscle strengthIt will be measured after 1 month

it will be measure in cm H2O

Trial Locations

Locations (1)

Cairo Unoversity

🇪🇬

Giza, Egypt

Cairo Unoversity
🇪🇬Giza, Egypt
Ali Ismail, lecturer
Contact
01005154209
allooka2012@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.